CERUS CORP (CERS) Stock Profile — Insider Trades & Financials

Net Income-$2.2M

EPS$-0.08

Market Cap$353.6M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

William M. Greenman

CEO & Executive Director

Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.

Employees: 254
Headquarters: CONCORD, CA, United States
Website: www.cerus.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-3.40%

ROA?

-0.98%

D/E Ratio?

2.44

📊

Profitability Ratios

Current Ratio?

1.73

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Jul 4, 2026 (in 88 days)

Annual Report (10-K) — Based on filing pattern

Jul 4, 2026

Predicted10-K

Mar 2, 2026

10-KQ4 202525d after period end

Nov 6, 2025

10-QQ3 202520d after period end

Aug 5, 2025

10-QQ2 202519d after period end

May 1, 2025

10-QQ1 202514d after period end

Feb 26, 2025

10-KQ4 202420d after period end

Oct 31, 2024

10-QQ3 202414d after period end

Aug 1, 2024

10-QQ2 202414d after period end

May 2, 2024

10-QQ1 202414d after period end

Loading company sections...

CERUS CORP

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness